ReShape Lifesciences Investor Relations Material

ReShape Lifesciences Inc. is a medical device company specializing in weight-loss solutions and metabolic health treatments. The company’s product portfolio includes minimally invasive devices designed to assist in weight management, such as intragastric balloon systems and laparoscopic medical implants. ReShape also provides support programs and digital tools to aid patients and healthcare providers in managing obesity and related health conditions. The company is headquartered in San Clemente, California, and its shares are listed on the NASDAQ Stock Exchange.